Study Finds Postmarketing Cardiac and Urticaria Safety Signals for Pericarditis Drug Rilonacept
A pharmacovigilance analysis of FAERS surveillance data and exploratory Mendelian randomization identified potential postmarketing safety signals for rilonacept, including allergic ...


